The effectiveness of a program of physical activity and diet to modify cardiovascular risk factors in patients with severe mental illness (CAPiCOR study)

International Archives of Medicine

Volumn 8, Issue 1, 2015, Pages

  Font, Roser Masa ^a   Sanmartín, Maria Isabel Fernández ^b   López, Luis Miguel Martín ^c   Tabueña, Noemí Olona ^b   Canet, Sílvia Oller ^d   Echevarría, Luisa San Emeterio ^e   Jato, Montserrat Ibarra ^f   Múgjica, Belén Díaz ^g   Tejón, Susana González ^b   Cabrera, Lidia Viñas ^b   Vitales, Celia Tajada ^b   Muñoz, Antonio Manuel Alba ^h   Catalán, Rosa Sanchís ^g   García, Albert Barroso ^b   Royo, Jaume Martín ^b   Barbarroja, Teresa Salvador ^e  

^a INSTITUT CATALÀ DE LA SALUT   (Spain)

^b Unitat Docent de Medicina Familiar i Comunitària ^*  (Spain)

^c HOSPITAL DEL MAR   (Spain)

^d Grup de Respiratori de la Societat Catalana de Medicina Familiar i Comunitria (Camfic)   (Spain)

^e Institut Catalá de Salut   (Spain)

^f Centre Salut Mental Martí i Juliá INAD   (Spain)

^g Centre Salut Mental Sant Martí Sud INAD   (Spain)

^h PARC SANITARI SANT JOAN DE DÉU   (Spain)

Author keywords

Bipolar disorder; Cardiovascular risk; Diet; Metabolic syndrome; Obesity; Physical activity; Quality of life; Schizophrenia; Severe mental disorder; Waist circumference

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET; DISEASE SEVERITY; FEMALE; HEALTH EDUCATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEDENTARY LIFESTYLE; WAIST CIRCUMFERENCE;

EID: 84929573912     PISSN: None     EISSN: 17557682     Source Type: Journal    
DOI: 10.3823/1696     Document Type: Article

References (39)

1. Perälä J, Suvisaari J, Saarni SI, Kuoppasalmi K, Isometsä E, Pirkola S, et al. Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population. Arch Gen Psychiatry. 2007 Jan; 64(1): 19-28.
2. Bobes J, Arango C, Aranda P, Carmena R, Garcia-Garcia M, Rejas J; CLAMORS Study Collaborative Group. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study. Eur Psychiatry. 2012 May; 27(4): 267-74.
3. Medeiros L, Obiols J, Navarro JB, Zúñiga A. Metabolic syndrome and health related quality of life in patients with schizophrenia. Actas Esp Psiquiatr 2013; 41(1): 17-26.
4. Laursen TM, Munk-Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatry. 2012 Mar; 25(2): 83-8.
5. Bou Khalil R. Metabolic syndrome in patients with schizophrenia independently from atypical antipsychotics intake. Presse Med.2012May; 41(5): e238-43.
6. Bellivier F. Schizophrenia, antipsychotics and diabetes: Genetic aspects. Eur Psychiatry. 2005 Dec; 20 Suppl 4: S335-9.
7. Compton MT, Daumit GL, Druss BG. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry. 2006 Jul-Aug; 14(4): 212-22.
8. Aguilar E, Coronas R, Caixàs A. Síndrome metabólico en pacientes esquizofrénicos con tratamiento antipsicótico. Med Clin (Barc). 2012; 139(12): 542-546.
9. O'Donell CJ, Elosua R. Cardiovascular risk factors. Insights from Framingham Heart Study. Rev Esp Cardiol. 2006 Mar; 61(3): 299-310.
10. Salas-Salvadó J, Rubio MA, Barbany M, Moreno B; Grupo Colaborativo de la SEEDO.Consenso SEEDO 2007 para la evaluación del sobrepeso y la obesidad y el establecimiento de criterios de intervención terapéutica. Med Clin (Barc). 2007 Feb; 128(5): 184-96.
11. Bernardo M, Grazia M. Esquizofrenia y Medicina de Familia. Implicaciones en Atención Primaria. Jano 2008; 1714: 37-44.
12. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews 2010, Issue 6. Art. No.: CD007253.
13. Faulkner G, Cohn T, Remington G. Interventions to reduce weight gain in schizophrenia. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD005148.
14. Holley J, Crone D, Tyson P, Lovell G. The effects of physical activity on psychological well-being for those with schizophrenia: A systematic review. Br J Clin Psychol. 2011 Mar; 50(1): 84-105.
15. Bernard P, Ninot G. Benefits of exercise for people with schizophrenia: a systematic review. Encephale. 2012 Sep; 38(4): 280-7.
16. Wu MK, Wang CK, Bai YM, Huang CY, Lee SD. Outcomes of obese, clozapine-treated inpatients with schizophrenia placed on a six-month diet and physical activity program. Psychiatr Serv.2007 April; 58: 544-550.
17. Daumit G, Dickerson F, Wang N, Dalcin A, Jerome G, Anderson C, Young D, Frick K, Yu A, Gennusa J, Oefinger M, Crum R, Charleston J, Casagrande S, Guallar E, Goldberg R, Campbell L, Appel L. A Behavioral Weight-Loss Intervention in Persons with Serious Mental Illness. N Engl J Med. 2013 Mar 21.
18. Fernández-San-Martín MI, Martín-López LM, Masa-Font R, Olona-Tabueña N, Roman Y, Martin-Royo J, et al. The Effectiveness of Lifestyle Interventions to Reduce Cardiovascular Risk in Patients with Severe Mental Disorders: Meta-Analysis of Intervention Studies. Community Ment Health J. DOI 10.1007/s10597-013-9614-6
19. Viron M, Baggett T, Hill M, Freudenreich O. Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population. Am J Med. 2012 Mar; 125(3): 223-30.
20. Sáiz J, Bobes J, Vallejo J, Giner J, García-Portilla MP; Grupo de Trabajo sobre la Salud Física del Paciente con Esquizofrenia. Consensus on physical health of patients with schizophrenia from the Spanish societies of Psychiatry. Actas Esp Psiquiatr. 2008; 36: 251-64.
21. Oud M, Meyboom-de Jong B. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Family Practice 2009, 10: 32
22. Viñas L, Fernández M, San Emeterio L, Martín-López LM; Grup Psicosi Litoral. Detección de factores de riesgo cardiovascular en pacientes con psicosis. Aten Primaria. 2011 Jul; 43(7): 386-7. doi: 10.1016/j.aprim.2010.04.021.
23. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, et al. International Physical Activity Questionnaire: 12 country reliability and validity. Med Sci Sports Exerc. 2003; 35: 1381-95.
24. Llibre blanc. Consens sobre les activitats preventives a l'edat adulta dins l'atenció primària. Barcelona (España): Direcció General de Salut Pública. Departament de Salud. Generalitat de Cataluña; 2005.
25. Vieta E, Torrent C, Martínez-Arán A, Colom F, Reinares M, Benabarre A et al. Escala sencilla de evaluación del curso del trastorno bipolar: CGI-BP-M. Actas Esp Psiquiatr. 2002; 30: 301-304.
26. Poulin MJ, Chaput JP, Simard V, Vincent P, Bernier J, Gauthier Y et al. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme. Australian and New Zealand Journal of Psychiatry. 2007; 41: 980-989.
27. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003; 35: 1381-95.
28. Marques A, Brotons C, Villar F, Lobos-Bejarano JM, Torcal J, Orozco-Beltrán, et al. Recomendaciones preventivas cardiovasculares PAPPS del 2009. Barcelona: semFYC ediciones, 2009: 101-113.
29. Marrugat J, Subirana I, Comin E, Cabezas C, Vila J, Elosua R, et al. Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA study. J Epidemiol Community Health. 2007; 61: 40-7.
30. Ware JE. SF36 health survey update. Spine (Phila Pa 1976). 2000; 25: 3130-9
31. Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM, et al. The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit. 2005; 19(2): 135-50.
32. Baena Diez JM, Barceló Colomer E, Ciurana Misol R, Franzi Sisó A, García Cordón MR, Rios Rodríguez MA, et al. Colesterol i risc coronari [guía en internet]. Barcelona: Institut Català de la Salut, 2009. Guies de pràctica clínica i material docent, núm 1 Disponible en: www.gencat.cat/ics/professionals/guies/colesterol/colesterol.htm.
33. Martinez-Gonzalez MA, Fernandez-Jarne E, Serrano-Martinez M, Wright M, Gomez-Gracia E. Development of a short dietary intake questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet. Eur J Clin Nutr. 2004; 58: 1550-2.
34. Estruch R, et al. Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med. 2013 Apr 4; 368(14): 1279-90.
35. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Pychological Reports. 1962; 10: 799-812
36. Casas E, Escandell MJ, Ribas M, Ochoa S. Instrumentos de evaluación en rehabilitación psicosocial. Rev. Asoc. Esp. Neuropsiq. 2010 Gen-Mar; 105: 25-47
37. Peralta V, Cuesta MJ. Validación de la escala de los síndromes positivo y negativo (PANSS) en una muestra de esquizofrénicos españoles. Actas Luso-Esp Neurol Psiquiatr. 1994; 4: 44-50.
38. Guy W. Clinical global impression (CGI). In: Guy W, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville: US Department of Health, Education and Welfare, Public Health Service, Alcohol, Drug Abuse and Mental Health Administration, NIMH. Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976. p. 218-22.
39. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impression (CGI) Scale for use in bipolar illness: the CGI-BP. Psychiatry Res. 1997; 73(3): 159-71.